Evidence map›Paper›PMID 24225488›Full record

ArticleNeuroImage2014

Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.

Talakad G Lohith, Sami S Zoghbi, Cheryl L Morse, Maria D Ferraris Araneta, Vanessa N Barth, Nancy A Goebl, Johannes T Tauscher, Victor W Pike, Robert B Innis, Masahiro Fujita

Abstract read
In one paragraph

Article in NeuroImage, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The opioid system in depression.Neuroscience and biobehavioral reviews · 2022
    Review
  7. Copper-Mediated Radiocyanation of Unprotected Amino Acids and Peptides.Journal of the American Chemical Society · 2022
    Article
  8. Review
  9. Article
  10. A Survey of Molecular Imaging of Opioid Receptors.Molecules (Basel, Switzerland) · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Effects of NOP-Related Ligands in Nonhuman Primates.Handbook of experimental pharmacology · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Nociceptin and the nociceptin receptor in learning and memory.Progress in neuro-psychopharmacology & biological psychiatry · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Talakad G LohithMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: lohithhere@gmail.com.
Sami S ZoghbiMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Cheryl L MorseMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Maria D Ferraris AranetaMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Vanessa N BarthEli Lilly & Co., Indianapolis, IN, USA.
Nancy A GoeblEli Lilly & Co., Indianapolis, IN, USA.
Johannes T TauscherEli Lilly & Co., Indianapolis, IN, USA.
Victor W PikeMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Robert B InnisMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: robert.innis@nih.gov.
Masahiro FujitaMolecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Eli Lilly (United States) · USNational Institute of Mental Health · USNational Institutes of Health · US

Funding

PET Radiopharmaceutical SciencesZIAMH002793 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI PIKE, VICTOR W · 2009 to 2025
$69.8M
Clinical Evaluation of PET RadiotracersZIAMH002852 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI INNIS, ROBERT · 2009 to 2025
$48.6M
Clinical Evaluation of PET RadiotracersZ01MH002852 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI INNIS, ROBERT · 2005 to 2008
$4.4M
Intramural NIH HHS Z01 MH002852Intramural NIH HHS Z99 MH999999
6 · The paper itself

Abstract

[(11)C]NOP-1A is a novel high-affinity PET ligand for imaging nociceptin/orphanin FQ peptide (NOP) receptors. Here, we report reproducibility and reliability measures of binding parameter estimates for [(11)C]NOP-1A binding in the brain of healthy humans. After intravenous injection of [(11)C]NOP-1A, PET scans were conducted twice on eleven healthy volunteers on the same (10/11 subjects) or different (1/11 subjects) days. Subjects underwent serial sampling of radial arterial blood to measure parent radioligand concentrations. Distribution volume (VT; a measure of receptor density) was determined by compartmental (one- and two-tissue) modeling in large regions and by simpler regression methods (graphical Logan and bilinear MA1) in both large regions and voxel data. Retest variability and intraclass correlation coefficient (ICC) of VT were determined as measures of reproducibility and reliability respectively. Regional [(11)C]NOP-1A uptake in the brain was high, with a peak radioactivity concentration of 4-7 SUV (standardized uptake value) and a rank order of putamen>cingulate cortex>cerebellum. Brain time-activity curves fitted well in 10 of 11 subjects by unconstrained two-tissue compartmental model. The retest variability of VT was moderately good across brain regions except cerebellum, and was similar across different modeling methods, averaging 12% for large regions and 14% for voxel-based methods. The retest reliability of VT was also moderately good in most brain regions, except thalamus and cerebellum, and was similar across different modeling methods averaging 0.46 for large regions and 0.48 for voxels having gray matter probability >20%. The lowest retest variability and highest retest reliability of VT were achieved by compartmental modeling for large regions, and by the parametric Logan method for voxel-based methods. Moderately good reproducibility and reliability measures of VT for [(11)C]NOP-1A make it a useful PET ligand for comparing NOP receptor binding between different subject groups or under different conditions in the same subject.

Indexed as

AdultArea Under CurveBrainCarbon RadioisotopesFemaleHumansMaleNociceptinNociceptin ReceptorOpioid PeptidesPositron-Emission TomographyRadiopharmaceuticalsReceptors, OpioidReproducibility of ResultsYoung AdultCarbon RadioisotopesNociceptinNociceptin ReceptorOpioid PeptidesOPRL1 protein, humanRadiopharmaceuticalsReceptors, Opioidarea-under-the-curveAUCbetween-subject mean sum of squaresBSMSSf(P)ICCintraclass correlation coefficientNociceptinnociceptin/orphanin FQ peptideNOPNOP receptorsPETplasma free fractionpositron emission tomographyretest variabilityTest–retest imagingtotal distribution volumeV(T)within-subject mean sum of squaresWSMSS

Identifiers

PMID24225488
PMCPMC3928240
OpenAlexW1988808525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.